These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The clinical prognostic significance of myocardial performance index (MPI) in stable placental-mediated disease. Bhorat I; Pillay M; Reddy T Cardiovasc J Afr; 2018 Sep/Oct 23; 29(5):310-316. PubMed ID: 30152840 [TBL] [Abstract][Full Text] [Related]
24. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation. Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854 [TBL] [Abstract][Full Text] [Related]
25. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730 [TBL] [Abstract][Full Text] [Related]
26. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses. Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727 [TBL] [Abstract][Full Text] [Related]
27. Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery. Sharabi-Nov A; Kumar K; Fabjan Vodušek V; Premru Sršen T; Tul N; Fabjan T; Meiri H; Nicolaides KH; Osredkar J Fetal Diagn Ther; 2020; 47(6):471-484. PubMed ID: 31778996 [TBL] [Abstract][Full Text] [Related]
28. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension. Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812 [TBL] [Abstract][Full Text] [Related]
29. Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. Chang KJ; Seow KM; Chen KH Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833689 [TBL] [Abstract][Full Text] [Related]
30. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Sheppard SJ; Khalil RA Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):33-52. PubMed ID: 20041838 [TBL] [Abstract][Full Text] [Related]
31. Uterine and umbilical artery doppler in women with pre-eclampsia and their pregnancy outcomes. Adekanmi AJ; Roberts A; Akinmoladun JA; Adeyinka AO Niger Postgrad Med J; 2019; 26(2):106-112. PubMed ID: 31187750 [TBL] [Abstract][Full Text] [Related]
32. Urinary Nephrin and Podocalyxin Levels as Predictors of Pre-eclampsia in High-Risk Pregnant Women. Kostovska I; Tosheska Trajkovska K; Kostovski O; Labudovic D Folia Med (Plovdiv); 2021 Dec; 63(6):948-957. PubMed ID: 35851239 [TBL] [Abstract][Full Text] [Related]
33. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Kametas NA; Nzelu D; Nicolaides KH Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217 [TBL] [Abstract][Full Text] [Related]
34. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation. Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058 [TBL] [Abstract][Full Text] [Related]
35. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial. Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361 [TBL] [Abstract][Full Text] [Related]
36. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787 [TBL] [Abstract][Full Text] [Related]
37. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction. Cetin I; Mazzocco MI; Giardini V; Cardellicchio M; Calabrese S; Algeri P; Martinelli A; Todyrenchuk L; Vergani P J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483 [TBL] [Abstract][Full Text] [Related]
38. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498 [TBL] [Abstract][Full Text] [Related]
39. Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre-eclampsia: validation and update of previous model. Mansukhani T; Wright A; Arechvo A; Laich A; Iglesias M; Charakida M; Nicolaides KH Ultrasound Obstet Gynecol; 2024 Feb; 63(2):230-236. PubMed ID: 37616530 [TBL] [Abstract][Full Text] [Related]
40. Pre-eclampsia: incidence, determinants, and pregnancy outcomes from maternity hospitals in Qatar: a population-based case-control study. Maducolil MK; Al-Obaidly S; Olukade T; Salama H; AlQubaisi M; Al Rifai H J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7831-7839. PubMed ID: 34112060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]